COMPANIES COVERED
Sun Pharm IndsDownload FREE Report Sample
Download Free sampleNimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker originally developed for the treatment of high blood pressure.
Nimodipine Market contains market size and forecasts of Nimodipine in global, including the following market information:
Global Nimodipine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nimodipine Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Nimodipine companies in 2021 (%)
The global Nimodipine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nimodipine include Sun Pharm Inds, Heritage Pharms, Bionpharma, Arbor Pharms, Thepharmanetwork, Sofgen Pharms and Bayer Vital GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nimodipine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nimodipine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Nimodipine Market Segment Percentages, by Type, 2021 (%)
Capsule
Solution
Tablets
Global Nimodipine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Nimodipine Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Clinics
Others
Global Nimodipine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Nimodipine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nimodipine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nimodipine revenues share in global market, 2021 (%)
Key companies Nimodipine sales in global market, 2017-2022 (Estimated), (MT)
Key companies Nimodipine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sun Pharm Inds
Heritage Pharms
Bionpharma
Arbor Pharms
Thepharmanetwork
Sofgen Pharms
Bayer Vital GmbH
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
